Certolizumab is a recombinant, polyethylene glycolated, antigen-binding fragment of a humanized monoclonal antibody that selectively targets and neutralizes tumor necrosis factor (TNF)-alpha, and may be used in psoriasis-related studies.
Purity:
>99.0%
CAS Number:
[428863-50-7]
* VAT and and shipping costs not included. Errors and price changes excepted
